STADA appoints Christos Gallis as head of Eastern Europe

German generics major STADA Arzneimittel (SAZ: Xetra) has named Christos Gallis as head of Eastern Europe, effective July 1, 2023.

At the same time, Mr Gallis will also become a member of the STADA executive committee, which consists of board members as well as executive vice-presidents of important business functions, representing all geographies of the STADA Group. He will be based at STADA’s headquarters in Bad Vilbel, Germany, and will report directly to chief executive Peter Goldschmidt.

In his new role, Mr Gallis will assume responsibility for STADA’s operations in Serbia and the West Balkans, Ukraine, Poland, Czech Republic, Slovakia, Bulgaria, Romania, Croatia, Slovenia, Greece, Hungary, Israel, Cyprus, the Baltic States and the Eurasia region encompassing several Commonwealth of Independent States (CIS) countries. Western European countries, such as France, Germany, Italy and the UK, as well as Russia, will continue to be led by Stephan Eder. Stephane Jacqmin continues to head STADA’s business in the Middle East, Africa and Asia.